EUVIMEDEUVIMED entdecken
Crossref

The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2

Reza Keikha, Ebrahim Balali, Ramona Khadivi, Ali Jebali iD

Viral Immunology · 2025

DOI: 10.1089/vim.2024.0099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viral Immunology, 2025. Verfasst von Reza Keikha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Nanoparticles, Toll-Like Receptor 4, SARS-CoV-2, Toll-Like Receptor 9. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesToll-Like Receptor 4SARS-CoV-2Toll-Like Receptor 9Adjuvants, ImmunologicCOVID-19COVID-19 VaccinesAnimalsMice, Inbred BALB CMiceHumansLipid AAntibodies, ViralFemaleHEK293 CellsLipidsSpike Glycoprotein, CoronavirusImmunoglobulin GRNA, ViralLiposomes

Stichwörter der Autor:innen

SARS-CoV-2TLR4 AgonistTLR9 Agonistlipid nanoparticlesself-amplifying RNA

Substanzen

Toll-Like Receptor 4monophosphoryl lipid ALipid AToll-Like Receptor 9Antibodies, ViralAdjuvants, ImmunologicLipid NanoparticlesCOVID-19 VaccinesLipidsSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Department of Pathology, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Department of Organic Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Department of Applied Chemistry, Faculty of Pharmaceutical Chemistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran.

ORCID-Profile: Ali Jebali

Zitieren

APA

Keikha, R., Balali, E., Khadivi, R., & Jebali, A. (2025). The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2. Viral Immunology. https://doi.org/10.1089/vim.2024.0099

Vancouver

Keikha R, Balali E, Khadivi R, Jebali A. The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2. Viral Immunology. 2025. doi:10.1089/vim.2024.0099

BibTeX
@article{Keikha2025,
  author = {Keikha, Reza and Balali, Ebrahim and Khadivi, Ramona and Jebali, Ali},
  title = {The Combination of TLR4 and TLR9 Agonists with Self-Amplifying RNA Lipid Nanoparticles Leads to a More Powerful Immune Response Against SARS-CoV-2},
  journal = {Viral Immunology},
  year = {2025},
  doi = {10.1089/vim.2024.0099}
}
Kostenlos starten →